This Article  • Full text  • PDF  • Send to a friend  • Save in My Folder  • Save to citation manager  • Permissions  Citing Articles  • Citation map  • Citing articles on HighWire  • Citing articles on ISI (10)  • Contact me when this article is cited  Related Content  • Related articles  • Similar articles in JAMA  Topic Collections  • Health Policy  • Immunization  • Alert me on articles by topic

Jon S. Abramson, MD; Larry K. Pickering, MD

JAMA. 2002;287:505-509.

	Since this article does not have an abstract, we have provided the first 150 words of the full text and any section headings.

During the past century, the average life expectancy of US citizens increased by 30 years, primarily due to improvements in sanitation and development and use of vaccines and antimicrobial agents.¹ Immunizations are one of the most cost-effective health intervention strategies available, saving society more than $5 for each dollar spent on most of the vaccines that are recommended routinely for children in the United States.² At the end of the 20th century, the percentage of children younger than 2 years who received all vaccines in the recommended childhood immunization schedule was at a record high of about 90%.³ Immunization is one of the major public health achievements of the 20th century.¹ Despite this remarkable success, the National Immunization Program has been subjected to increasing attacks by a number of individuals and groups. We highlight the benefits of the vaccines in the recommended . . . [Full Text of this Article]

Successes

Author Affiliations: Wake Forest University School of Medicine, Winston-Salem, NC (Dr Abramson); and Committee on Infectious Diseases, American Academy of Pediatrics, Elk Grove Village, Ill (Dr Abramson); and the National Immunization Program, Centers for Disease Control and Prevention, and Department of Pediatrics, Emory University School of Medicine, Atlanta, Ga (Dr Pickering).

RELATED ARTICLES

The Changing Epidemiology of Rubella in the 1990s: On the Verge of Elimination and New Challenges for Control and Prevention
Susan E. Reef, Teryl K. Frey, Katherine Theall, Emily Abernathy, Cindy L. Burnett, Joseph Icenogle, Mary Mason McCauley, and Melinda Wharton
JAMA. 2002;287(4):464-472.
ABSTRACT | FULL TEXT  

Rubella
JAMA. 2002;287(4):542.
PDF  

THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Incorporating Vaccine-Preventable Disease Surveillance Into the National Health Information Network: Leveraging Children's Hospitals
Fine et al.
Pediatrics 2006;118:1431-1438.
ABSTRACT | FULL TEXT  

Implications of a 2005 measles outbreak in Indiana for sustained elimination of measles in the United States.
Parker et al.
NEJM 2006;355:447-455.
ABSTRACT | FULL TEXT  

Will Coverage for Child and Adolescent Immunizations Be Mandated for Insurance Plans in 2006? Lessons Learned From the Newborns' and Mothers' Health Protection Act of 1996
Mmeje and Davis
Pediatrics 2006;118:388-392.
FULL TEXT  

Could It Happen Here? Vaccine Risk Controversies And The Specter Of Derailment
Colgrove and Bayer
Health Aff (Millwood) 2005;24:729-739.
ABSTRACT | FULL TEXT  

Strategies to Improve Immunization Rates and Well-Child Care in a Disadvantaged Population: A Cluster Randomized Controlled Trial
Hambidge et al.
Arch Pediatr Adolesc Med 2004;158:162-169.
ABSTRACT | FULL TEXT  

Control of Disease Attributable to Haemophilus influenzae Type b and the National Immunization Program
Meissner and Pickering
Pediatrics 2002;110:820-823.
FULL TEXT